Streptococcus Pneumoniae Antikörper

Produktnummer ABIN110942

Der Maus Monoklonal anti-Streptococcus Pneumoniae Antikörper wird verwendet zum Nachweis von Streptococcus Pneumoniae in Proben von Streptococcus pneumoniae. Er wurde validiert für IF und EIA.

Kurzübersicht für Streptococcus Pneumoniae Antikörper (ABIN110942)

Target: Streptococcus Pneumoniae

Reaktivität: Streptococcus pneumoniae

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser Streptococcus Pneumoniae Antikörper ist unkonjugiert

Applikation: Immunofluorescence (IF), Enzyme Immunoassay (EIA)

Klon: 128-390

Produktdetails anti-Streptococcus Pneumoniae Antikörper

Aufreinigung: Affinity Chromatography on Protein A.

Immunogen: Native S. pneumoniae (NCTC 10319).

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: ELISA. Immunofluorescence.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1.0 mg/mL

Buffer: PBS, pH 7.2 containing 0.09 % Sodium Azide as preservative.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Details zu Streptococcus Pneumoniae

Target: Streptococcus Pneumoniae

Substanzklasse: Bacteria

Hintergrund: Bronchial pneumonia is most prevalant in infants, young children and aged adults. It is caused by various bacteria, including Streptococcus pneumoniae. Streptococcus pneumoniae are Gram positive, lancet shaped cocci (elongated cocci with a slightly pointed outer curvature). Usually they are seen as pairs of cocci (diplococci), but they may also occur singly and in short chains. S. pneumoniae is a transient member of the normal flora, colonizing the nasopharynx of 40 % of healthy adults and children with no adverse effects. There are more than 90 serotypes: serotypes 6, 14, 18, 19, and 23 are the most prevalent accounting for 60-80 % of infections depending on the area of the world. Pneumococcal infection accounts for more deaths than any other vaccine preventable bacterial disease.